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Abstract. Telemedicine frameworks are key to screening the large, ever-
growing diabetic population for preventable blindness due to diabetic
retinopathy (DR). Integrating fully-automated screening systems in tele-
medicine frameworks will make DR screening more efficient, cost-effective,
reproducible, and accessible. In this paper, we present the integration of
EyeArt, an automated DR screening system, into EyePACS, a telemedicine
system for DR screening used in diverse screening settings. EyeArt in-
corporates novel image processing and analysis algorithms for assessing
image gradability; enhancing images based on median filtering; detecting
interest regions and localizing lesions based on multi-scale morphological
analysis; and DR screening and thus achieves robustness to the large im-
age variability seen in a telemedicine system such as EyePACS. EyeArt
is implemented as a scalable, high-throughput cloud-based system to en-
able large-scale DR screening. We evaluate the safety and performance
of EyeArt on a dataset with 434,023 images from 54,324 patient cases
obtained from EyePACS. On this dataset, EyeArt’s screening sensitivity
is 90% at specificity 60.8% and the area under the receiver operating
characteristic curve (AUROC) is 0.883. In a setup where trained hu-
man graders review patient cases recommended for referral by EyeArt
with low confidence, a workload reduction of 62% is possible. Therefore,
EyeArt can be safely integrated into large real world telemedicine DR
screening programs such as EyePACS helping reduce workload and in-
crease efficiency and thus help in reducing vision loss due to DR through
early detection and treatment.
Keywords: image analysis, telemedicine, screening, diabetic retinopa-
thy, EyeArt, EyePACS
1 Introduction
Diabetes mellitus is a chronic disease that impairs insulin production which in
turn hampers the body’s ability to metabolize glucose. The number of people
with diabetes worldwide is estimated to be a staggering 387 million in 2014 [10].
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With the increase in diabetes incidence and the relatively low diabetes mortality,
the prevalence of diabetes is expected to increase and reach 592 million by 2035
[10].
Diabetic retinopathy (DR) is a common microvascular complication of di-
abetes in which blood vessels in the retina become fragile and leak. DR is the
leading cause of new-onset blindness and vision loss among the working-age pop-
ulation in the western world [9], with approximately 24,000 people losing vision
from DR each year in the US alone. Studies have demonstrated that early detec-
tion and treatment of DR helps reduce blindness and vision loss [11] and that DR
screening is cost-effective [11]. Therefore, annual DR screening is recommended
for diabetic patients [9].
Many diabetic patients do not get annual DR screening since DR can progress
over several years without symptoms or discomfort before reaching a stage with
vision loss. In addition, today eye care providers cannot meet the screening needs
of the large and growing diabetic population with manual DR screening alone.
In order to address the lack of adherence with yearly eye exams, DR screening
programs [6, 4, 1, 3] have been developed in primary care facilities using non-
invasively captured digital color fundus images that are read remotely by trained
graders in a telemedicine system. EyePACS [6] is a well established telemedicine
program that provides a web-based DR screening framework designed to simplify
the process of image capture, transmission, and review.
A fully-automated computerized screening system used for triaging patient
cases will go a long way in reducing the workload of trained graders in telemedicine
programs and thus make the DR screening process more efficient, cost-effective,
reproducible, and accessible. Therefore, integrating automated DR screening sys-
tems in telemedicine systems is key to meeting the fast-growing need for DR
screening for preventable blindness.
Many automated programs have been developed over the years to interpret
retinal images, however, they have generally been tested against standard refer-
ence retinal image databases, such as MESSIDOR [12], Diaret1db [7], or DRIVE
[13], which provide ground truth in hundreds of retinal images for testing. While
these image sets are generally carefully adjudicated for retinal lesions and vas-
culature, they may not represent the variety of retinal images that are captured
in real world DR screening environments. Image interpretation algorithms that
perform well on standard retinal image databases may perform inadequately
when deployed in actual clinical practice where image quality, pupil size, fundus
pigmentation, illumination conditions, and retinal cameras are quite variable.
Eyenuk’s EyeArt program [2] is an automated high-throughput DR screen-
ing system that has performed well when tested against the EyePACS database
of retinal images captured in actual clinical settings using a variety of fundus
cameras. In this paper we present the integration of EyeArt, an automated DR
screening system, into the EyePACS Retinal Reading Program, a telemedicine
system for DR screening. We evaluate the safety and performance of EyeArt
on a large color retinal fundus image dataset with 54,324 patient cases obtained
from EyePACS and show that EyeArt achieves a high sensitivity of 90% at speci-
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ficity of 60.8% for identifying patients requiring referral with AUROC of 0.883.
EyeArt’s excellent performance on the EyePACS dataset with large variability
across images can be primarily attributed to the novel image processing and
analysis algorithms used for assessing gradability of images; enhancing images;
segmenting and localizing lesions; and DR screening based on all images in a
patient visit.
2 System Design and Approach
2.1 EyePACS telemedicine system
Primary care clinic personnel (nursing, technical, or administrative staff) are
trained and certified by the EyePACS program coordinators to acquire retinal
images from standard digital retinal cameras. Relevant clinical data and eight
high-resolution images per patient (two external and 6 retinal images) are en-
crypted and transmitted to a secure server using a standard computer and web
browser. Images are then interpreted by certified EyePACS reviewers or local
eye care providers who are certified through the EyePACS Retinopathy Grading
System (ERGS). Reports indicating retinopathy level and referral recommen-
dations are transmitted back to primary care providers through the EyePACS
website or through interfaces between EyePACS and Health Level 7-compliant
electronic medical records or chronic disease registries.
EyePACS uses an image evaluation protocol, the EyePACS Retinopathy
Grading System (ERGS), developed by Bresnick [6] and based on the Early
Treatment Diabetic Retinopathy Study (ETDRS) [8]. The protocol evaluates
the presence and severity of the discrete retinal lesions associated with diabetic
retinopathy. The lesions graded are shown in Figure 1. In addition, the presence
or absence of laser scars (focal and panretinal) is graded. Readers grade each
lesion type separately in each eye using an online grading template which records
a choice for each lesion type among: absent [“no”], present [“yes”] or [“cannot
grade”].
Fig. 1. EyePACS grading template
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Based on the severity of discrete retinal lesions, each patient visit is assigned a
DR severity level as per the International Clinical Diabetic Retinopathy (ICDR)
scale [5] with 0 for no apparent DR; 1 for mild non-proliferative DR (NPDR); 2
for moderate NPDR; 3 for severe NPDR; and 4 for proliferative DR (PDR), and
a Macular Edema (ME) level with 0 for no ME and 1 for ME. A patient was
deemed to have non-referable DR if there was no NPDR or mild NPDR and no
ME in both eyes.
2.2 EyeArt - Automated DR screening
EyeArt is a computerized screening tool developed by Eyenuk, Inc. that assesses
the severity of DR based on multiple color fundus images captured during a
patient visit or encounter, and provides a recommendation for referral to an
eye-care specialist if the patient is deemed to have ME or moderate NPDR or
higher on the ICDR scale. The primary output of EyeArt is a “refer” or “no
refer” screening recommendation. EyeArt is designed to provide a “refer” rec-
ommendation when it detects signs of moderate NPDR or higher on the ICDR
scale; detects signs of ME; or deems the images as ungradable. EyeArt outputs
a decision statistic that can be used to assess the confidence in the recommen-
dation. In addition, EyeArt provides a “confident refer” recommendation using
thresholds at 98% specificity.
The overall block diagram of the EyeArt system is shown in Figure 2. The
patient encounter comprising multiple color fundus images is first analyzed for
gradability. Non-retinal images such as those of the external image of the eye,
retinal images with poor quality due to various factors such as poor illumination,
over-exposure and poor focus are excluded from further analysis. If the patient
encounter has at least one retinal image with acceptable quality per eye, it
is deemed as gradable. Non-gradable patient encounters are not analyzed and
flagged as having insufficient data.
Image enhancement: Retinal fundus images have different colors levels,
different dynamic range, and different sensor noise. Image enhancement is nec-
essary to normalize the appearance and enhance the appearance of lesions (See
figure 3). For enhancement, the gradable images are first subjected to an edge-
preserving bilateral filter [14] in order to remove noise without affecting the
important landmarks such as lesions and vessels.
Fig. 2. Overall block diagram of EyeArt DR screening system
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The median normalized image intensity INorm,S at pixel location (x, y) is
computed as,
INorm,S(x, y) =
{
Cmid + (Cmid − 1) · I(x,y)−IBack,S(x,y)Cmax−IBack,S(x,y) if I(x, y) ≥ IBack,S(x, y),
Cmid · I(x,y)IBack,S(x,y) otherwise ,
(1)
where I is the input image with pixel intensities in the range [Cmin, Cmax] =
[0, 2B − 1], B is the image bit-depth, IBack,S is background image obtained
using a median filter over the area S , and Cmid = 2B−1 is the “middle” gray
pixel intensity value in image I. For an 8-bit image, [Cmin, Cmax] = [0, 255], and
Cmid = 128. Empirically, S is chosen to be a circle of radius r=100.
Interest region identification: The enhanced images are then analyzed
to identify regions of the image potentially containing interesting anatomical
or pathological structures. The interest region detector based on multi-scale
morphological filterbank analysis that identifies putative lesion-specific interest
regions (See figure 4).
Descriptor computation: The pixels identified by the interest region de-
tector are described using a set of feature descriptors (multi-scale median filter-
bank descriptors, oriented median filterbank descriptors, and other established
descriptors) that allow local description at multiple scales. The interesting pixels
are classified using supervised learning classifiers into lesion types (See figure 5).
DR screening classification: The pixel-level classifier decision statistics
are averaged within each lesion to obtain the lesion-level decision statistics. The
histograms of lesion-level decision statistics for different lesion types are col-
lated to generate the image-level descriptor. The image-level descriptors for all
the gradable images in a patient encounter/visit are combined to generate an
encounter-level descriptor that is classified using a supervised learning ensemble
classifier to detect the presence of moderate NPDR or higher on the ICDR scale.
2.3 Integration of EyeArt into EyePACS
The EyeArt interface has been designed to be REST-ful and hence can be ac-
cessed via standard HTTPS requests. The design for the integration of EyeArt
automated screening system into the EyePACS telemedicine screening frame-
work is shown in Figure 6. The patient images are passed on to the EyeArt
Fig. 3. Improved lesion and vessel visibility after enhancement. The inset shows en-
hanced microaneurysms.
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Fig. 4. Examples of interest regions identification. A: Original image showing lesions
(bright yellow and dark red spots). B: Binary map showing interesting pixels forming
less than 1% of the total pixels in the image.
Fig. 5. Example of fully-automated lesion localization and segmentation by EyeArt. A:
Microaneurysms B: Hemorrhages. C: Exudates. Most of these lesions in this example
retinal image are correctly detected and localized.
system from EyePACS via a HTTPS POST request after removal of patient
identifying data and assigning a unique patient ID. The EyePACS system pings
the EyeArt system via HTTPS GET requests for results of the patient encounter
which are provided when available.
3 Dataset and results
The EyePACS dataset included a total of 434,023 color retinal fundus images
of 54,324 diabetic patient visits or encounters without any patient identification
data. Each of these encounters had 2-24 images including external lens-shots.
These deidentified images were captured between April 2006 and December 2013
at various DR screening centers that use the EyePACS Retinal Reading Program.
The prevalence of the various DR levels on the ICDR scale and ME as per
the gold standard grading provided by EyePACS graders is tabulated in Table
1. A total of 8,189 cases (15.1% of the cases) were deemed to have referable DR
(moderate NPDR or higher); 1,965 cases (3.6% of the cases) were deemed to
have treatable DR (severe NPDR or higher) and 2,339 cases (4.3% of the cases)
were deemed to have ME. No case was deemed by graders to be ungradable due
to poor quality.
All the 54,324 encounters from the EyePACS dataset were processed by Eye-
Art in about 24 hours. EyeArt marks 500 encounters (0.9%) as non-gradable and
these encounters are considered to have a “refer” recommendation for the per-
formance analysis. EyeArt screening sensitivity is 90% (95% CI: 89.4% – 90.6%)
at specificity of 60.8% (95% CI: 60.4% – 61.3%) at an operating point of -0.875
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Fig. 6. Interface between the EyePACS telemedicine screening system and the EyeArt
automated screening tool.
on the decision statistic. This corresponds to 25,491 “refer” recommendations,
4,830 of which are “confident refer” recommendations with high confidence i.e.
at 98% specificity thresholds. The AUROC is 0.883 (95% CI: 0.878 – 0.887). As
shown in Table 2, there are 828 false negatives (only 1.5% of the cases) out of
which 724 do not meet the treatment criteria [5] i.e. have moderate NPDR and
no macular edema. A careful analysis of the false negative cases reveals that
most of the misses are either in cases of questionable image quality or where the
missed lesions are very faint.
The screening sensitivity of EyeArt at reasonable specificity values is better
than the sensitivities achieved by human graders. If all the 25,491 cases in the
EyePACS dataset for which EyeArt provides a “refer” recommendation are re-
viewed by human graders, the graders’ workload is reduced by 53% compared
to the system without EyeArt where they see all patient images. Of the 25,491
Table 1. Distribution of DR levels and ME levels in the EyePACS dataset as per gold
standard grading
ICDR scale
Number of cases (Percentage of cases)
Without ME With ME Total
No apparent DR (0) 40683 (74.9) 0 ( 0.0) 40683 (74.9)
Mild NPDR (1) 5359 ( 9.9) 14 ( 0.0) 5373 ( 9.9)
Moderate NPDR (2) 4922 ( 9.1) 1302 ( 2.4) 6224 (11.5)
Severe NPDR (3) 560 ( 1.0) 576 ( 1.1) 1136 ( 2.1)
Proliferative DR (4) 461 ( 0.8) 368 ( 0.7) 829 ( 1.5)
DR level unknown (-1) 0 ( 0.0) 79 ( 1.4) 79 ( 1.4)
Ungradable due to poor quality 0 ( 0.0) 0 ( 0.0) 0 ( 0.0)
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 Table 2. Analysis of EyeArt false negatives in the EyePACS dataset with 54,324 cases. 
The 724 missed cases with moderate NPDR and no ME do not meet treatment criteria.
ICDR scale
Number of false negatives
Without ME With ME Total
Moderate NPDR (2) 724 72 796
Severe NPDR (3) 10 4 14
PDR (4) 17 1 18
“refer” recommendations, if the 4,830 “confident refer” recommendations are not
seen by graders, their workload is reduced by 62% (or by factor of 2.6).
4 Conclusion
EyeArt achieves high sensitivity (90% at 60.8% specificity) for identifying pa-
tients with referable DR on 434,023 retinal images of 54,324 patients from the
EyePACS telescreening system. Our analysis also shows that EyeArt can pro-
vide a workload reduction of 62%. To the best of our knowledge, this is the first
time an automated DR screening system has been validated on a large, real-
world dataset with more than 50,000 patient visits. The results demonstrate that
EyeArt can be safely integrated into image reading centers within telemedicine
frameworks and can help increase efficiency and cost-savings by reducing the
workload of trained graders. Automated retinal image analysis for DR screening
integrated into telemedicine systems has the potential to greatly reduce the bur-
den on DR screening systems by improving health care productivity and thus
help in reducing vision loss due to DR through early detection and treatment.
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